Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kunyining (also known as Kunyining Granules) is a Traditional Chinese Medicine (TCM) therapeutic developed by the Zhejiang Institute of Traditional Chinese Medicine. It is formulated as an oral granule intended for the treatment of menopausal syndrome, specifically targeting the "kidney yin and yang deficiency" syndrome. As a botanical-based product, it consists of a proprietary blend of herbal extracts designed to restore physiological balance and alleviate symptoms such as hot flashes, sweating, and mood changes associated with the perimenopausal period. The drug has undergone Phase II clinical testing in China to evaluate its safety and efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kunyining.